Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
American Society for Clinical Investigation
Online
2019-02-15
DOI
10.1172/jci124108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+T-Cell–Driven Antitumor Immunity
- (2018) Sarah L. Buchan et al. CLINICAL CANCER RESEARCH
- HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers
- (2018) Sara I. Pai et al. ORAL ONCOLOGY
- Macrophages and CD8 + T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
- (2018) Jennifer Q. Zhang et al. Cancer Immunology Research
- Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
- (2017) Shan Zeng et al. MOLECULAR CANCER THERAPEUTICS
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor
- (2017) Shan Zeng et al. Oncotarget
- A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke
- (2017) Hsu-Tung Lee et al. Theranostics
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas
- (2017) François Bertucci et al. OncoImmunology
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab
- (2016) Sandra P. D'Angelo et al. CLINICAL CANCER RESEARCH
- PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors
- (2016) Adrian M. Seifert et al. CLINICAL CANCER RESEARCH
- RNA sequencing validation of the Complexity INdex in SARComas prognostic signature
- (2016) Tom Lesluyes et al. EUROPEAN JOURNAL OF CANCER
- CXCL14 as an emerging immune and inflammatory modulator
- (2016) Jing Lu et al. Journal of Inflammation-London
- FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors
- (2016) Eileen Shi et al. Journal of Translational Medicine
- Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14
- (2016) Louis Cicchini et al. mBio
- NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets
- (2016) Morten Nielsen et al. Genome Medicine
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial
- (2014) Christopher L. Corless et al. JOURNAL OF CLINICAL ONCOLOGY
- Quadruplewild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways
- (2014) Maria A. Pantaleo et al. Cancer Medicine
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- KIT oncogene inhibition drives intratumoral macrophage M2 polarization
- (2013) Michael J. Cavnar et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA typing from RNA-Seq sequence reads
- (2012) Sebastian Boegel et al. Genome Medicine
- Succinate Dehydrogenase-Deficient GISTs
- (2011) Markku Miettinen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Management of Gastrointestinal Stromal Tumors: A Model for Targeted and Multidisciplinary Therapy of Malignancy
- (2011) Heikki Joensuu et al. Annual Review of Medicine
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
- (2011) Vinod P Balachandran et al. NATURE MEDICINE
- Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
- (2011) Françoise Ducimetière et al. PLoS One
- Natural Killer Cell IFN- Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients
- (2009) C. Menard et al. CANCER RESEARCH
- Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
- (2009) Jason S Gold et al. LANCET ONCOLOGY
- NetMHCpan, a method for MHC class I binding prediction beyond humans
- (2008) Ilka Hoof et al. IMMUNOGENETICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started